1. Home
  2. PLSM vs ICU Comparison

PLSM vs ICU Comparison

Compare PLSM & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$1.57

Market Cap

11.6M

Sector

Health Care

ML Signal

N/A

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

N/A

Current Price

$2.21

Market Cap

13.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSM
ICU
Founded
2014
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
13.3M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
PLSM
ICU
Price
$1.57
$2.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
26.1K
★ 220.8K
Earning Date
08-31-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,234,000.00
Revenue This Year
N/A
$62.07
Revenue Next Year
N/A
$46.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 814.07
52 Week Low
$1.62
$0.22
52 Week High
$12.97
$5.38

Technical Indicators

Market Signals
Indicator
PLSM
ICU
Relative Strength Index (RSI) 26.79 33.81
Support Level N/A N/A
Resistance Level $2.64 $2.82
Average True Range (ATR) 0.16 0.30
MACD 0.01 -0.10
Stochastic Oscillator 0.00 1.12

Price Performance

Historical Comparison
PLSM
ICU

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: